from	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
man	1:0,0,0,0;3:0,0,0,0;5:0,0,0,0
to	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
molecule	1:0,0,0,0;1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
and	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
back	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
mankind	1:0,0,0,0
by	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
w	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
illiam	1:0,0,0,0
b.	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;6:0,0,0,0
castle	1:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
acfarlane	1:0,0,0,0
burnet,	1:0,0,0,0
in	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
commenting	1:0,0,0,0
upon	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0
the	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
value	1:0,0,0,0
general	1:0,0,0,0;6:0,0,0,0
m	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
biology	1:0,0,0,0;5:0,0,0,0
of	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
study	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
disease,	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;3:0,0,0,0;3:0,0,0,0
wisely	1:0,0,0,0
remarked;	1:0,0,0,0
“	1:0,0,0,0;2:0,0,0,0
it	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
is	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
only	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
when	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
something	1:0,0,0,0
goes	1:0,0,0,0
wrong	1:0,0,0,0
with	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
that	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
we	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
may	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
recognize	1:0,0,0,0
existence	1:0,0,0,0
a	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
normal	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
mechanism.”	1:0,0,0,0
thus,	1:0,0,0,0;1:0,0,0,0
depth	1:0,0,0,0
sickle	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
cell	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
disease	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
has	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
led	1:0,0,0,0;3:0,0,0,0
revela	1:0,0,0,0
tions	1:0,0,0,0;5:0,0,0,0;5:0,0,0,0
concerning	1:0,0,0,0;1:0,0,0,0
genetic	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
control	1:0,0,0,0
mode	1:0,0,0,0
synthesis	1:0,0,0,0
hemo	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
globin	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
at	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
molecular	1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
level.	1:0,0,0,0
clinical	1:0,0,0,0;1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
observations	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
followed	1:0,0,0,0;4:0,0,0,0
basic	1:0,0,0,0
re	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
search	1:0,0,0,0
condition	1:0,0,0,0;1:0,0,0,0;3:0,0,0,0
principally	1:0,0,0,0
affecting	1:0,0,0,0;1:0,0,0,0;4:0,0,0,0
some	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
members	1:0,0,0,0
black	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;4:0,0,0,0
african	1:0,0,0,0
race	1:0,0,0,0
come	1:0,0,0,0
progressively	1:0,0,0,0;2:0,0,0,0
better	1:0,0,0,0;4:0,0,0,0
understanding	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0
this	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
other	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
biological	1:0,0,0,0
phenomena	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
involved	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0
life	1:0,0,0,0;4:0,0,0,0;5:0,0,0,0
processes	1:0,0,0,0
all	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
races	1:0,0,0,0
man.	1:0,0,0,0
for	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0
information	1:0,0,0,0;1:0,0,0,0;5:0,0,0,0
owe	1:0,0,0,0
debt	1:0,0,0,0
gratitude	1:0,0,0,0
victims	1:0,0,0,0
further	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0
research	1:0,0,0,0
their	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0
collaboration	1:0,0,0,0
can	1:0,0,0,0;1:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
hopefully	1:0,0,0,0
be	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
repaid	1:0,0,0,0
near	1:0,0,0,0;3:0,0,0,0
future	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0
through	1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
benefit	1:0,0,0,0;4:0,0,0,0
them.	1:0,0,0,0;4:0,0,0,0
because	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
doctor	1:0,0,0,0
ham	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
was	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
pio	1:0,0,0,0
neer	1:0,0,0,0
mechanism	1:0,0,0,0;3:0,0,0,0;5:0,0,0,0
red	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
destruction	1:0,0,0,0;2:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
perhaps	1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
appropriate	1:0,0,0,0;5:0,0,0,0
contributor	1:0,0,0,0
volume	1:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
his	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
honor	1:0,0,0,0
review	1:0,0,0,0;6:0,0,0,0
historical	1:0,0,0,0;1:0,0,0,0
development	1:0,0,0,0;2:0,0,0,0
our	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0
knowledge	1:0,0,0,0;4:0,0,0,0
disorder.	1:0,0,0,0
n	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
history	1:0,0,0,0
likened	1:0,0,0,0
opening	1:0,0,0,0
proverbial	1:0,0,0,0
russian	1:0,0,0,0
egg;	1:0,0,0,0
once	1:0,0,0,0;1:0,0,0,0;4:0,0,0,0
another	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;4:0,0,0,0
egg	1:0,0,0,0
appears	1:0,0,0,0
within,	1:0,0,0,0
inside	1:0,0,0,0;1:0,0,0,0
yet	1:0,0,0,0;1:0,0,0,0
so	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
on.	1:0,0,0,0
first	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
see	1:0,0,0,0
ailing	1:0,0,0,0
anemic	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
patient,	1:0,0,0,0;4:0,0,0,0
then	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0
deoxygenated,	1:0,0,0,0;3:0,0,0,0
sickled	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
cell,	1:0,0,0,0;4:0,0,0,0;5:0,0,0,0
its	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
abnormal	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
hemoglobin,	1:0,0,0,0;2:0,0,0,0
finally	1:0,0,0,0;4:0,0,0,0
hidden	1:0,0,0,0
away	1:0,0,0,0
beta	1:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0
chain	1:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0
molecule,	1:0,0,0,0;4:0,0,0,0
single	1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
displaced	1:0,0,0,0
aminoacid.	1:0,0,0,0
must	1:0,0,0,0;5:0,0,0,0;5:0,0,0,0
said	1:0,0,0,0
that,	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0
about	1:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
which	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
much	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0
fundamental	1:0,0,0,0;2:0,0,0,0
known,	1:0,0,0,0
seems	1:0,0,0,0;4:0,0,0,0
remarkable	1:0,0,0,0
prevention	1:0,0,0,0
therapy	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0
have	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
just	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0
made	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
beginning.	1:0,0,0,0
this,	1:0,0,0,0;3:0,0,0,0
however,	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
no	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
means	1:0,0,0,0;4:0,0,0,0
unique	1:0,0,0,0
situation	1:0,0,0,0
management	1:0,0,0,0
human	1:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
disease;	1:0,0,0,0
witness	1:0,0,0,0
failure	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0
prevent	1:0,0,0,0
vascular	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;6:0,0,0,0
complications	1:0,0,0,0
diabetes	1:0,0,0,0
sovereign	1:0,0,0,0
remedy	1:0,0,0,0
hand	1:0,0,0,0
or	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
indifference	1:0,0,0,0
public	1:0,0,0,0;4:0,0,0,0;5:0,0,0,0
well-established	1:0,0,0,0
dangerous	1:0,0,0,0
effects	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
cigarette	1:0,0,0,0
smoking.	1:0,0,0,0
although	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0
there	1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
are	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
promising	1:0,0,0,0
therapeutic	1:0,0,0,0;4:0,0,0,0;5:0,0,0,0
agents,	1:0,0,0,0
none	1:0,0,0,0;5:0,0,0,0
as	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
fully	1:0,0,0,0;3:0,0,0,0
effective	1:0,0,0,0
without	1:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
disadvantage.	1:0,0,0,0
again,	1:0,0,0,0
unfess	1:0,0,0,0
healthy	1:0,0,0,0
par	1:0,0,0,0
ents	1:0,0,0,0
unrecognized	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0
trait	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
informed	1:0,0,0,0
they	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
do	1:0,0,0,0;2:0,0,0,0
not	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
know	1:0,0,0,0;4:0,0,0,0
child	1:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0
born	1:0,0,0,0
them	1:0,0,0,0;2:0,0,0,0
who	1:0,0,0,0;2:0,0,0,0
will	1:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
shortly	1:0,0,0,0
develop	1:0,0,0,0
disease.	1:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
indebted	1:0,0,0,0
konotey-ahulu	1:0,0,0,0;5:0,0,0,0
korle	1:0,0,0,0;3:0,0,0,0
bu	1:0,0,0,0
teaching	1:0,0,0,0
hospital	1:0,0,0,0
perspective	1:0,0,0,0
“severe”	1:0,0,0,0
“not-so-severe”	1:0,0,0,0
types	1:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
long	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
been	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
recognized	1:0,0,0,0
ghana,	1:0,0,0,0
conditions	1:0,0,0,0
children	1:0,0,0,0
seemingly	1:0,0,0,0;2:0,0,0,0
parents.	1:0,0,0,0
krobo	1:0,0,0,0
tribe	1:0,0,0,0
medical	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
service,	1:0,0,0,0
veterans	1:0,0,0,0
administration	1:0,0,0,0;4:0,0,0,0
hospital,	1:0,0,0,0
ivest	1:0,0,0,0
roxbury,	1:0,0,0,0
mass.,	1:0,0,0,0
de-	1:0,0,0,0;5:0,0,0,0
partment	1:0,0,0,0
oj	1:0,0,0,0
medicine,	1:0,0,0,0
harvard	1:0,0,0,0
school.	1:0,0,0,0
boston.	1:0,0,0,0
mass.	1:0,0,0,0
presented	1:0,0,0,0
part	1:0,0,0,0;3:0,0,0,0
national	1:0,0,0,0;5:0,0,0,0
symposium	1:0,0,0,0
on	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
washington.	1:0,0,0,0
d.c..	1:0,0,0,0
june	1:0,0,0,0
27,	1:0,0,0,0
1974.	1:0,0,0,0
©	1:0,0,0,0
1976	1:0,0,0,0;1:0,0,0,0
grune	1:0,0,0,0;6:0,0,0,0
<&	1:0,0,0,0
stratton.	1:0,0,0,0
inc.	1:0,0,0,0
159	1:0,0,0,0
vol.	1:0,0,0,0
13,	1:0,0,0,0
no.	1:0,0,0,0
2	1:0,0,0,0
(april),	1:0,0,0,0
s	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0
e	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0
i	1:0,0,0,0
r	1:0,0,0,0;4:0,-0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
h	1:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
t	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
o	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
l	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0
g	1:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
y	1:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
,	1:0,0,0,0
il	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
ia	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
c	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
160	2:0,0,0,0
161	2:0,0,0,0
lecule	2:0,0,0,0;5:0,0,0,0
traced	2:0,0,0,0
one	2:0,0,0,0;4:0,0,0,0
family	2:0,0,0,0;3:0,0,0,0
three	2:0,0,0,0
centuries.^’	2:0,0,0,0
definite	2:0,0,0,0
recognition	2:0,0,0,0
ol	2:0,0,0,0
these	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
were	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
very	2:0,0,0,0
eharacteristic	2:0,0,0,0
hemoglobin	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
authors	2:0,0,0,0
apparently	2:0,0,0,0;2:0,0,0,0
ascribed	2:0,0,0,0;3:0,0,0,0
sickling	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
anomalous	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
behavior	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
an	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;6:0,0,0,0;6:0,0,0,0
entity	2:0,0,0,0
became	2:0,0,0,0
possible	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
country	2:0,0,0,0;4:0,0,0,0
after	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
1910	2:0,0,0,0
rather	2:0,0,0,0
than	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
species	2:0,0,0,0
james	2:0,0,0,0;6:0,0,0,0
herrick^®	2:0,0,0,0
chicago	2:0,0,0,0
reported	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
association	2:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
american	2:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
globin?	2:0,0,0,0
indeed,	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
latter	2:0,0,0,0
explanation	2:0,0,0,0;2:0,0,0,0
proposed	2:0,0,0,0;3:0,0,0,0
until	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
1948	2:0,0,0,0;5:0,0,0,0
janet	2:0,0,0,0
physicians	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
appearance	2:0,0,0,0
under	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
microscope	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
“peculiar	2:0,0,0,0
elongated	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
watson""	2:0,0,0,0
downstate	2:0,0,0,0
medieal	2:0,0,0,0;2:0,0,0,0
center,	2:0,0,0,0
brooklyn,	2:0,0,0,0
n.y.,	2:0,0,0,0
inferred	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
de	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
sickle-shaped	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
blood	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
corpuscles”	2:0,0,0,0
fixed	2:0,0,0,0
fresh	2:0,0,0,0
films	2:0,0,0,0
lay	2:0,0,0,0
full	2:0,0,0,0
vitro	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
induced	2:0,0,0,0
siekling	2:0,0,0,0;2:0,0,0,0
infant’s	2:0,0,0,0
west	2:0,0,0,0
indian	2:0,0,0,0
student	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
severe	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
anemia	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
heart	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
murmur.	2:0,0,0,0
he	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
cau	2:0,0,0,0
weeks	2:0,0,0,0
birth	2:0,0,0,0
due	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
gradual	2:0,0,0,0
replaeement	2:0,0,0,0
fetal	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
tiously	2:0,0,0,0
suggested	2:0,0,0,0;2:0,0,0,0
“some	2:0,0,0,0
change	2:0,0,0,0;4:0,0,0,0
she	2:0,0,0,0
said,	2:0,0,0,0
...	2:0,0,0,0
adult	2:0,0,0,0;5:0,0,0,0
type	2:0,0,0,0;5:0,0,0,0
possesses	2:0,0,0,0
composition	2:0,0,0,0
corpuscle	2:0,0,0,0;2:0,0,0,0
itself	2:0,0,0,0;2:0,0,0,0
determining	2:0,0,0,0
factor.”	2:0,0,0,0
property.”	2:0,0,0,0
response	2:0,0,0,0
profession	2:0,0,0,0
announcement	2:0,0,0,0
even	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
meanwhile	2:0,0,0,0
relation	2:0,0,0,0;5:0,0,0,0
eell	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
more	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
lethargic	2:0,0,0,0
classic	2:0,0,0,0
description	2:0,0,0,0;5:0,0,0,0
coronary	2:0,0,0,0;4:0,0,0,0
occlusion	2:0,0,0,0;3:0,0,0,0
two	2:0,0,0,0
years	2:0,0,0,0;4:0,0,0,0
elinical	2:0,0,0,0
aspeets	2:0,0,0,0
had	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
progressing.	2:0,0,0,0
1930	2:0,0,0,0
later.	2:0,0,0,0
scriver	2:0,0,0,0;5:0,0,0,0
waugh^*	2:0,0,0,0
confirmed	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
prediction	2:0,0,0,0
hahn	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
gillespie‘s	2:0,0,0,0
1917	2:0,0,0,0;5:0,0,0,0
v.	2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
e.	2:0,0,0,0
emmel'^	2:0,0,0,0
observed	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
what	2:0,0,0,0;5:0,0,0,0
considered	2:0,0,0,0
transitional	2:0,0,0,0
forms	2:0,0,0,0;2:0,0,0,0
found	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
cells,	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
less	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
oxygen,	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
earbon	2:0,0,0,0
dioxide	2:0,0,0,0
samples	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
between	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
disk-shaped	2:0,0,0,0
cells	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
young	2:0,0,0,0;4:0,0,0,0
venous	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
extremity	2:0,0,0,0
subjected	2:0,0,0,0
experimental	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0
stasis.	2:0,0,0,0;4:0,0,0,0
mulatto	2:0,0,0,0
woman	2:0,0,0,0
experienced	2:0,0,0,0
recurrent	2:0,0,0,0
leg	2:0,0,0,0
ulcers.	2:0,0,0,0
saw	2:0,0,0,0
improved	2:0,0,0,0;5:0,0,0,0
eounts	2:0,0,0,0
patient	2:0,0,0,0;3:0,0,0,0
fol	2:0,0,0,0
nucleated	2:0,0,0,0
form	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
biconcave	2:0,0,0,0
disks	2:0,0,0,0
assumed	2:0,0,0,0
correctly	2:0,0,0,0
lowing	2:0,0,0,0
spleneetomy	2:0,0,0,0
gillespie	2:0,0,0,0;5:0,0,0,0
already	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
correetly	2:0,0,0,0
acquired	2:0,0,0,0
release	2:0,0,0,0
marrow;	2:0,0,0,0
enlarged	2:0,0,0,0;4:0,0,0,0
spleen	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
merely	2:0,0,0,0
performing	2:0,0,0,0
usual	2:0,0,0,0;4:0,0,0,0
“hemoclastic	2:0,0,0,0
function”	2:0,0,0,0
but	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
transformation	2:0,0,0,0
satisfaction	2:0,0,0,0
sealed	2:0,0,0,0;2:0,0,0,0
“cultures”	2:0,0,0,0
“too	2:0,0,0,0
discriminating.”	2:0,0,0,0
1939	2:0,0,0,0;5:0,0,0,0
diggs	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
bibb"	2:0,0,0,0
demonstrated	2:0,0,0,0;4:0,0,0,0
increased	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
patient’s	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
suspended	2:0,0,0,0
her	2:0,0,0,0;2:0,0,0,0
own	2:0,0,0,0
serum.	2:0,0,0,0
moreover,	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
culture	2:0,0,0,0
meehanieal	2:0,0,0,0
fragility	2:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
deoxygenated	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
siekled	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
eells	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
later	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
shen	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
et	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
father’s	2:0,0,0,0
blood,	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
though	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
normal,	2:0,0,0,0
likewise	2:0,0,0,0
developed	2:0,0,0,0
al.^^	2:0,0,0,0
1946	2:0,0,0,0
earefully	2:0,0,0,0
studied	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
lange	2:0,0,0,0;5:0,0,0,0
al.^*	2:0,0,0,0;3:0,0,0,0
1951.	2:0,0,0,0
beeause	2:0,0,0,0
days	2:0,0,0,0;4:0,0,0,0
“forms	2:0,0,0,0
sharp	2:0,0,0,0
projections	2:0,0,0,0
elongations.”	2:0,0,0,0
here	2:0,0,0,0;2:0,0,0,0
then,	2:0,0,0,0
bibb	2:0,0,0,0;5:0,0,0,0
few	2:0,0,0,0
patients	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
permanently	2:0,0,0,0
pleural	2:0,0,0,0
now	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
know,	2:0,0,0,0
distinguished	2:0,0,0,0
time	2:0,0,0,0;3:0,0,0,0
hematologic	2:0,0,0,0
features	2:0,0,0,0
ascitie	2:0,0,0,0
fluids	2:0,0,0,0
stagnation	2:0,0,0,0
deoxy	2:0,0,0,0
homozygous	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
heterozygous	2:0,0,0,0
phenotypes,	2:0,0,0,0
reversible	2:0,0,0,0;2:0,0,0,0
genated	2:0,0,0,0
might	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
responsible.	2:0,0,0,0
1949	2:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
al.^“	2:0,0,0,0
produced	2:0,0,0,0
sueh	2:0,0,0,0
ex	2:0,0,0,0;5:0,0,0,0
so-called	2:0,0,0,0;3:0,0,0,0
“irreversibly	2:0,0,0,0
sickled”	2:0,0,0,0
cells.	2:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
perimentally	2:0,0,0,0
24-hr	2:0,0,0,0
incubation	2:0,0,0,0
blood.	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
publication	2:0,0,0,0;6:0,0,0,0
fourteenth	2:0,0,0,0
case	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
oxygenated,	2:0,0,0,0
irreversibly	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
usually	2:0,0,0,0
contain	2:0,0,0,0;3:0,0,0,0
gillespie'*’	2:0,0,0,0
1927	2:0,0,0,0;5:0,0,0,0
clearly	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
defined	2:0,0,0,0
factors	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
state	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
recently	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
shown	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
bertles	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
milner,*	2:0,0,0,0
jensen	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0
acute	2:0,0,0,0
phenomenon.	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
al.,^'*	2:0,0,0,0
others	2:0,0,0,0
permanent	2:0,0,0,0
deformity	2:0,0,0,0
caleium-loaded	2:0,0,0,0
rigidity	2:0,0,0,0;3:0,0,0,0
implication	2:0,0,0,0
excellent	2:0,0,0,0
procedures	2:0,0,0,0
membrane	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
rendering	2:0,0,0,0
subjeet	2:0,0,0,0
rapid	2:0,0,0,0
vivo.	2:0,0,0,0
1940	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
scribed	2:0,0,0,0
was,	2:0,0,0,0
remain	2:0,0,0,0
over	2:0,0,0,0;4:0,0,0,0
years:	2:0,0,0,0
namely,	2:0,0,0,0;2:0,0,0,0
20	2:0,0,0,0
castle,'’	2:0,0,0,0
noting	2:0,0,0,0
markedly	2:0,0,0,0;3:0,0,0,0
viseosity	2:0,0,0,0
abnormal.	2:0,0,0,0
dr.	2:0,0,0,0
oxygenated	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
siekle	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
vitro,	2:0,0,0,0
initiation	2:0,0,0,0
colleague	2:0,0,0,0
employed	2:0,0,0,0
hanging	2:0,0,0,0
drop	2:0,0,0,0
preparations	2:0,0,0,0
could	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
capillary	2:0,0,0,0;3:0,0,0,0
bed,	2:0,0,0,0;4:0,0,0,0
result	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
reduetion	2:0,0,0,0
oxygen	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
tension	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
directly	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
continuously	2:0,0,0,0
exposed	2:0,0,0,0
quick	2:0,0,0,0
there,	2:0,0,0,0
would	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
slow	2:0,0,0,0
loeal	2:0,0,0,0
circulation,	2:0,0,0,0
reduce	2:0,0,0,0
changes	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
known	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
tensions	2:0,0,0,0;3:0,0,0,0
carbon	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
dioxide,	2:0,0,0,0;3:0,0,0,0
gases.	2:0,0,0,0
augment	2:0,0,0,0
viseosity,	2:0,0,0,0
initiate	2:0,0,0,0
“vieious	2:0,0,0,0;2:0,0,0,0
cyele	2:0,0,0,0
erythro-	2:0,0,0,0
noted	2:0,0,0,0;3:0,0,0,0
occurred	2:0,0,0,0
partial	2:0,0,0,0;4:0,0,0,0
pressure	2:0,0,0,0;2:0,0,0,0
fell	2:0,0,0,0
45	2:0,0,0,0
mm	2:0,0,0,0
stasis.”	2:0,0,0,0
eycle,	2:0,0,0,0
describable	2:0,0,0,0
today	2:0,0,0,0;4:0,0,0,0
“positive	2:0,0,0,0
feedbaek	2:0,0,0,0
loop”	2:0,0,0,0
thought	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
hg,	2:0,0,0,0
provided	2:0,0,0,0;5:0,0,0,0
hydrogen	2:0,0,0,0;2:0,0,0,0
ion	2:0,0,0,0;2:0,0,0,0
concentration	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
acid	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
side	2:0,0,0,0;4:0,0,0,0
account	2:0,0,0,0
episodie	2:0,0,0,0
incidenee	2:0,0,0,0
painful	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
crises.	2:0,0,0,0
also	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
pub	2:0,0,0,0
ph	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0
7.4.	2:0,0,0,0
monoxide	2:0,0,0,0
promptly	2:0,0,0,0
restored	2:0,0,0,0
discoid	2:0,0,0,0
lication	2:0,0,0,0
julius	2:0,0,0,0
bauer"*	2:0,0,0,0
appeared	2:0,0,0,0
define	2:0,0,0,0
end	2:0,0,0,0;3:0,0,0,0
products	2:0,0,0,0
postulated	2:0,0,0,0
form.	2:0,0,0,0
corpuscles	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
lost	2:0,0,0,0;3:0,0,0,0
did	2:0,0,0,0;2:0,0,0,0
hypoxia.	2:0,0,0,0
eyele”	2:0,0,0,0
many	2:0,0,0,0
organs	2:0,0,0,0
seen	2:0,0,0,0;3:0,0,0,0
pathologist	2:0,0,0,0
autopsy:	2:0,0,0,0
throm	2:0,0,0,0
consequently	2:0,0,0,0
stated:	2:0,0,0,0
bosis,	2:0,0,0,0
isehemia,	2:0,0,0,0
neerosis,	2:0,0,0,0
fibrosis.	2:0,0,0,0
return	2:0,0,0,0
progress	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0;6:0,0,0,0
toward	2:0,0,0,0;2:0,0,0,0
molecule.	2:0,0,0,0;3:0,0,0,0
i.	2:0,0,0,0
j.	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;6:0,0,0,0
sherman,	2:0,0,0,0
while	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
formalion	2:0,0,0,0;2:0,0,0,0
phenomenon	2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
depending	2:0,0,0,0
ihe	2:0,0,0,0;2:0,0,0,0
free	2:0,0,0,0
combined	2:0,0,0,0
slale	2:0,0,0,0
lhe	2:0,0,0,0
susceptible	2:0,0,0,0
corpuscles.	2:0,0,0,0;5:0,0,0,0
.	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
losl	2:0,0,0,0
working	2:0,0,0,0;4:0,0,0,0
wintrobe’s	2:0,0,0,0
laboratory	2:0,0,0,0;3:0,0,0,0
johns	2:0,0,0,0
hopkins,	2:0,0,0,0
iheir	2:0,0,0,0
lo	2:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
undergo	2:0,0,0,0
consislenl	2:0,0,0,0
wilh	2:0,0,0,0
hypolhesis	2:0,0,0,0
relaling	2:0,0,0,0
equilibration	2:0,0,0,0
air	2:0,0,0,0;3:0,0,0,0
distortion	2:0,0,0,0
hemoglobin.	2:0,0,0,0;3:0,0,0,0
reasonable	2:0,0,0,0
suppose	2:0,0,0,0
formed	2:0,0,0,0
redueed	2:0,0,0,0
barometrie	2:0,0,0,0
pressure.	2:0,0,0,0
eonfirmed	2:0,0,0,0
thesis	2:0,0,0,0
gillespie'*	2:0,0,0,0
body	2:0,0,0,0
affected	2:0,0,0,0
person	2:0,0,0,0
wherever	2:0,0,0,0
concentra	2:0,0,0,0
well	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
differenee	2:0,0,0,0
bloods	2:0,0,0,0
diggs'®	2:0,0,0,0
1932	2:0,0,0,0;5:0,0,0,0
tion	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
such	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
render	2:0,0,0,0
distorted	2:0,0,0,0
stable.	2:0,0,0,0
preparations.	2:0,0,0,0;5:0,0,0,0
sherman*’	2:0,0,0,0
nonanemic	2:0,0,0,0
pa	2:0,0,0,0;3:0,0,0,0
tients	2:0,0,0,0
required	2:0,0,0,0
mueh	2:0,0,0,0
greater	2:0,0,0,0;4:0,0,0,0
reduction	2:0,0,0,0
barometric	2:0,0,0,0
lueid	2:0,0,0,0
exposition	2:0,0,0,0
aseribed	2:0,0,0,0
before	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
those	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
anemia.	2:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
contents	2:0,0,0,0
lowered	2:0,0,0,0;4:0,0,0,0
enhaneed	2:0,0,0,0
“without	2:0,0,0,0
interpretation”	2:0,0,0,0
novel	2:0,0,0,0
observation	2:0,0,0,0
great	2:0,0,0,0;3:0,0,0,0
potential	2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
significance:	2:0,0,0,0
crease	2:0,0,0,0
ph.	2:0,0,0,0
relating	2:0,0,0,0
characteristic	2:0,0,0,0
birefringent	2:0,0,0,0;3:0,0,0,0
polarizing	2:0,0,0,0
162	3:0,0,0,0
163	3:0,0,0,0
le	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
u	3:0,0,0,0;4:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
microscope,	3:0,0,0,0
property	3:0,0,0,0;3:0,0,0,0
unsickling	3:0,0,0,0
aeration.	3:0,0,0,0
chance	3:0,0,0,0;5:0,0,0,0
modification	3:0,0,0,0
permits	3:0,0,0,0
deoxygenation	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
way	3:0,0,0,0;4:0,0,0,0
cause	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
six	3:0,0,0,0
stacks	3:0,0,0,0
orientation	3:0,0,0,0;5:0,0,0,0
associated	3:0,0,0,0;5:0,0,0,0
molecules	3:0,0,0,0;3:0,0,0,0
become	3:0,0,0,0
twisted	3:0,0,0,0
around	3:0,0,0,0
each	3:0,0,0,0;6:0,0,0,0;6:0,0,0,0
helix	3:0,0,0,0
communicated	3:0,0,0,0
friend	3:0,0,0,0
physical	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
chem	3:0,0,0,0
high	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
pitch	3:0,0,0,0
elegant	3:0,0,0,0
work	3:0,0,0,0
murayama,	3:0,0,0,0
bertles,	3:0,0,0,0
finch,	3:0,0,0,0
ddbler,	3:0,0,0,0
ist,	3:0,0,0,0
linus	3:0,0,0,0
pauling,	3:0,0,0,0
1946.	3:0,0,0,0
aroused	3:0,0,0,0
interest	3:0,0,0,0
demonstra	3:0,0,0,0
white,	3:0,0,0,0
others.”	3:0,0,0,0
pauling	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
al.^'	3:0,0,0,0
clear-cut	3:0,0,0,0
differences	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
elec	3:0,0,0,0
singer	3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
singer'"'	3:0,0,0,0
1953	3:0,0,0,0;5:0,0,0,0
allison'	3:0,0,0,0
1957	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
among	3:0,0,0,0
trophoretic	3:0,0,0,0
mobilities	3:0,0,0,0
hemoglobins.	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
quantitate	3:0,0,0,0
minimum	3:0,0,0,0
gelling	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
concentrations	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
viscosity	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
showed	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
contrast	3:0,0,0,0
both	3:0,0,0,0
mixtures	3:0,0,0,0
well-	3:0,0,0,0
roughly	3:0,0,0,0
equal	3:0,0,0,0;3:0,0,0,0
amounts.	3:0,0,0,0
allowed	3:0,0,0,0
severity	3:0,0,0,0
ranging	3:0,0,0,0
ss	3:0,0,0,0
infer	3:0,0,0,0
neep	3:0,0,0,0
university	3:0,0,0,0
michigan	3:0,0,0,0
published	3:0,0,0,0
heterozygotes	3:0,0,0,0
hbsoarab.	3:0,0,0,0
hbsd,	3:0,0,0,0
hbsc,	3:0,0,0,0
hbs-thalassemia,	3:0,0,0,0
hbs-	3:0,0,0,0;4:0,0,0,0
basis	3:0,0,0,0
studies,	3:0,0,0,0
benign	3:0,0,0,0;3:0,0,0,0
hetero	3:0,0,0,0
bu,	3:0,0,0,0
hbsa,	3:0,0,0,0;3:0,0,0,0
hbs-high	3:0,0,0,0
f	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
correlate	3:0,0,0,0
fairly	3:0,0,0,0
results	3:0,0,0,0;3:0,0,0,0
zygous	3:0,0,0,0
responsible	3:0,0,0,0
measurement	3:0,0,0,0;4:0,0,0,0
vitro.	3:0,0,0,0;5:0,0,0,0
greenberg	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
al.'*	3:0,0,0,0;3:0,0,0,0
tient	3:0,0,0,0
whose	3:0,0,0,0;3:0,0,0,0
hemoglobins	3:0,0,0,0;4:0,0,0,0
discussing	3:0,0,0,0
electrophoretic	3:0,0,0,0;3:0,0,0,0
depleted	3:0,0,0,0
iron	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
deficiency,	3:0,0,0,0
al.^‘	3:0,0,0,0
surface	3:0,0,0,0
region	3:0,0,0,0
atom	3:0,0,0,0
hbs	3:0,0,0,0;4:0,0,0,0
above	3:0,0,0,0
10	3:0,0,0,0;4:0,0,0,0
gm/loo	3:0,0,0,0
ml.	3:0,0,0,0
is,	3:0,0,0,0
absent	3:0,0,0,0
altogether	3:0,0,0,0
clear	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
whether	3:0,0,0,0
permit	3:0,0,0,0;4:0,0,0,0
complementary	3:0,0,0,0
interaction	3:0,0,0,0
whole	3:0,0,0,0;3:0,0,0,0
individual	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
capillaries	3:0,0,0,0;3:0,0,0,0
causing	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
blockade	3:0,0,0,0
tween	3:0,0,0,0
alignment,	3:0,0,0,0
birefringence,	3:0,0,0,0
dis	3:0,0,0,0;5:0,0,0,0
important.	3:0,0,0,0
harris	3:0,0,0,0;5:0,0,0,0;5:0,0,0,0
1956	3:0,0,0,0;5:0,0,0,0
critically	3:0,0,0,0;3:0,0,0,0
examined	3:0,0,0,0
direct	3:0,0,0,0
tortion	3:0,0,0,0
membrane.	3:0,0,0,0;4:0,0,0,0
consequently,	3:0,0,0,0
called	3:0,0,0,0
lationship	3:0,0,0,0
unsaturation,	3:0,0,0,0
sickling,	3:0,0,0,0
viscosity,	3:0,0,0,0
me	3:0,0,0,0
“a	3:0,0,0,0
disease.”	3:0,0,0,0
remained	3:0,0,0,0
w.	3:0,0,0,0;6:0,0,0,0
harris'*	3:0,0,0,0
demon	3:0,0,0,0
chanical	3:0,0,0,0
strate	3:0,0,0,0
reality	3:0,0,0,0
interpretation	3:0,0,0,0
following	3:0,0,0,0
year.	3:0,0,0,0
patients.	3:0,0,0,0
conducted	3:0,0,0,0
presence	3:0,0,0,0;3:0,0,0,0
abnormally	3:0,0,0,0
ten	3:0,0,0,0;3:0,0,0,0
sions	3:0,0,0,0
experiments	3:0,0,0,0
progressive	3:0,0,0,0;3:0,0,0,0
cell-free	3:0,0,0,0
solutions	3:0,0,0,0
parameters	3:0,0,0,0
began	3:0,0,0,0
higher	3:0,0,0,0
came	3:0,0,0,0
viscous	3:0,0,0,0
displayed	3:0,0,0,0
phase	3:0,0,0,0
spindle-	3:0,0,0,0
jandl	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
al.”	3:0,0,0,0
1961	3:0,0,0,0;5:0,0,0,0
shaped	3:0,0,0,0
bodies	3:0,0,0,0
approximating	3:0,0,0,0
size.	3:0,0,0,0
“liquid	3:0,0,0,0
cyrstals”	3:0,0,0,0
filterability	3:0,0,0,0;3:0,0,0,0
various	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
“tactoids”	3:0,0,0,0
polarized	3:0,0,0,0
light.	3:0,0,0,0
journey	3:0,0,0,0;3:0,0,0,0
sions.	3:0,0,0,0
using	3:0,0,0,0
5-n	3:0,0,0,0
millipore	3:0,0,0,0
filter	3:0,0,0,0
25%	3:0,0,0,0
decrease	3:0,0,0,0;3:0,0,0,0
completed.	3:0,0,0,0
compared	3:0,0,0,0
cells;	3:0,0,0,0
decreasing	3:0,0,0,0
k	3:0,0,0,0
d	3:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
marked	3:0,0,0,0;4:0,0,0,0
filterability.	3:0,0,0,0
initial	3:0,0,0,0
difference	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
ir	3:0,0,0,0;5:0,0,0,0
course	3:0,0,0,0
trait,	3:0,0,0,0
reversibly	3:0,0,0,0;5:0,0,0,0
membranes	3:0,0,0,0
sa	3:0,0,0,0
heterozygote,	3:0,0,0,0
up	3:0,0,0,0;4:0,0,0,0
nearly	3:0,0,0,0
half	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
klug	3:0,0,0,0;5:0,0,0,0
reviewed	3:0,0,0,0
rheology	3:0,0,0,0
instructive	3:0,0,0,0
video	3:0,0,0,0
tape	3:0,0,0,0
recordings	3:0,0,0,0
harmless	3:0,0,0,0
unless	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
allows	3:0,0,0,0
conspire	3:0,0,0,0
microscopic	3:0,0,0,0
appearances	3:0,0,0,0
passing	3:0,0,0,0
sufficient	3:0,0,0,0
fellows	3:0,0,0,0
distort	3:0,0,0,0
cell.	3:0,0,0,0;3:0,0,0,0
mesenteric	3:0,0,0,0
rat	3:0,0,0,0
during	3:0,0,0,0;3:0,0,0,0
breathing	3:0,0,0,0;4:0,0,0,0
5%	3:0,0,0,0;4:0,0,0,0
oxygen.	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
fect	3:0,0,0,0;5:0,0,0,0
finding	3:0,0,0,0
cannot	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
explained	3:0,0,0,0
technique	3:0,0,0,0
yields	3:0,0,0,0
clearest	3:0,0,0,0
picture	3:0,0,0,0
all-important	3:0,0,0,0
events	3:0,0,0,0
consequence	3:0,0,0,0;5:0,0,0,0
conspiracy.	3:0,0,0,0
reason	3:0,0,0,0
initiating	3:0,0,0,0;4:0,0,0,0
vivo,	3:0,0,0,0
becomes	3:0,0,0,0
equally	3:0,0,0,0
inspect	3:0,0,0,0
discussion	3:0,0,0,0
aggregation	3:0,0,0,0;4:0,0,0,0
bed	3:0,0,0,0
retina	3:0,0,0,0
man,	3:0,0,0,0
where	3:0,0,0,0;4:0,0,0,0
vascu	3:0,0,0,0
relevant	3:0,0,0,0
mankind.	3:0,0,0,0
fascinating	3:0,0,0,0
lar	3:0,0,0,0
damage	3:0,0,0,0;5:0,0,0,0
readily	3:0,0,0,0;4:0,0,0,0
life.*	3:0,0,0,0
tails	3:0,0,0,0
configuration	3:0,0,0,0
whatever	3:0,0,0,0
implications	3:0,0,0,0
vivo	3:0,0,0,0
taken	3:0,0,0,0
together	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
al	3:0,0,0,0
provide	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
relief	3:0,0,0,0
sufferer	3:0,0,0,0
clin	3:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
low	3:0,0,0,0
us	3:0,0,0,0
understand	3:0,0,0,0
considerable	3:0,0,0,0
degree	3:0,0,0,0
ical	3:0,0,0,0
immediate	3:0,0,0,0
intact	3:0,0,0,0
affect	3:0,0,0,0
organs.	3:0,0,0,0
sudden	3:0,0,0,0
sequestra	3:0,0,0,0
suffice	3:0,0,0,0
recall	3:0,0,0,0
well-known	3:0,0,0,0
“finger	3:0,0,0,0
print”	3:0,0,0,0
method,	3:0,0,0,0
devised	3:0,0,0,0
enlarging	3:0,0,0,0
most	3:0,0,0,0;5:0,0,0,0
dra	3:0,0,0,0
vernon	3:0,0,0,0
ingram^'	3:0,0,0,0
1957,	3:0,0,0,0
mobility	3:0,0,0,0
matic	3:0,0,0,0
event,	3:0,0,0,0
same	3:0,0,0,0
process	3:0,0,0,0;5:0,0,0,0
commonly	3:0,0,0,0;4:0,0,0,0
leads	3:0,0,0,0
charge	3:0,0,0,0;5:0,0,0,0
caused	3:0,0,0,0;4:0,0,0,0
substitution	3:0,0,0,0;3:0,0,0,0
hyperplasia	3:0,0,0,0
atrophy	3:0,0,0,0
spleen.	3:0,0,0,0
comprehensible	3:0,0,0,0
aminoacid,	3:0,0,0,0
valine,	3:0,0,0,0
glutamic	3:0,0,0,0
trypsin-derived	3:0,0,0,0
pep	3:0,0,0,0
similar	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
stagnation,	3:0,0,0,0
embolism,	3:0,0,0,0
infarction	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
especially	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
tide	3:0,0,0,0
sixth	3:0,0,0,0
posi	3:0,0,0,0
beds	3:0,0,0,0
lung	3:0,0,0,0;4:0,0,0,0
liver,	3:0,0,0,0
“down	3:0,0,0,0
stream”	3:0,0,0,0
n-terminal	3:0,0,0,0
chain.	3:0,0,0,0
alpha	3:0,0,0,0
polypeptide	3:0,0,0,0
any	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
set	3:0,0,0,0;4:0,0,0,0
systemic	3:0,0,0,0
capillaries.	3:0,0,0,0
lag	3:0,0,0,0
seconds	3:0,0,0,0
unaltered.	3:0,0,0,0
single,	3:0,0,0,0
genetically	3:0,0,0,0
controlled,	3:0,0,0,0
begins,	3:0,0,0,0
“milking”	3:0,0,0,0
action	3:0,0,0,0
organ	3:0,0,0,0
vessels,	3:0,0,0,0
164	4:0,0,0,0
165	4:0,0,0,0
explain	4:0,0,0,0;4:0,0,0,0
relative	4:0,0,0,0
immu	4:0,0,0,0
rouleaux	4:0,0,0,0
formation.	4:0,0,0,0;5:0,0,0,0
should	4:0,0,0,0
obviously	4:0,0,0,0
added:	4:0,0,0,0
arterial	4:0,0,0,0;4:0,0,0,0
nity	4:0,0,0,0
crisis,	4:0,0,0,0
despite	4:0,0,0,0
hypoxia,	4:0,0,0,0;4:0,0,0,0
dehydration,	4:0,0,0,0
acidosis,	4:0,0,0,0
vasospasm,	4:0,0,0,0
congestive	4:0,0,0,0
veins.	4:0,0,0,0
hand,	4:0,0,0,0
cardiac	4:0,0,0,0
output	4:0,0,0,0
anemia,	4:0,0,0,0;5:0,0,0,0
sometimes	4:0,0,0,0;4:0,0,0,0
un	4:0,0,0,0
priori	4:0,0,0,0
too	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
difficult	4:0,0,0,0
challenge	4:0,0,0,0
aside	4:0,0,0,0
saturation	4:0,0,0,0
jeopardized	4:0,0,0,0
embolization	4:0,0,0,0
pulmonary	4:0,0,0,0;4:0,0,0,0
effect	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
mutation	4:0,0,0,0
gene,	4:0,0,0,0
somatically	4:0,0,0,0
seem	4:0,0,0,0;4:0,0,0,0
cardiomegaly,	4:0,0,0,0
murmurs,	4:0,0,0,0
eventual	4:0,0,0,0
conges	4:0,0,0,0
tive	4:0,0,0,0;5:0,0,0,0
failure.	4:0,0,0,0
early	4:0,0,0,0
reversibility	4:0,0,0,0
hyposthenuria	4:0,0,0,0
hematuria	4:0,0,0,0
trans	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
significant	4:0,0,0,0
alteration	4:0,0,0,0
molecule’s	4:0,0,0,0
ability	4:0,0,0,0
take	4:0,0,0,0;5:0,0,0,0
fusion	4:0,0,0,0
hydration,	4:0,0,0,0
irreversible	4:0,0,0,0
hyposthenuria,	4:0,0,0,0
lease	4:0,0,0,0
colonize	4:0,0,0,0
innocuously	4:0,0,0,0
bone	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
marrow	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
erythropoietic	4:0,0,0,0;4:0,0,0,0
repeated	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
special	4:0,0,0,0;5:0,0,0,0;6:0,0,0,0
interest.	4:0,0,0,0
renal	4:0,0,0,0;5:0,0,0,0
dysfunctions	4:0,0,0,0
decreased	4:0,0,0,0
transfusions	4:0,0,0,0;4:0,0,0,0
achieved.	4:0,0,0,0
if	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
machinery	4:0,0,0,0
inserted	4:0,0,0,0
rate	4:0,0,0,0;5:0,0,0,0
flow,	4:0,0,0,0
hypertonicity	4:0,0,0,0
operating	4:0,0,0,0
sick	4:0,0,0,0
committed	4:0,0,0,0
trick	4:0,0,0,0
turned.	4:0,0,0,0
ling	4:0,0,0,0
traversing	4:0,0,0,0
hairpin	4:0,0,0,0
loops	4:0,0,0,0
peritubular	4:0,0,0,0
vasa	4:0,0,0,0
recta	4:0,0,0,0
medulla.''^	4:0,0,0,0
hopeful	4:0,0,0,0;5:0,0,0,0
prospect	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
nature	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
knows	4:0,0,0,0
how	4:0,0,0,0;4:0,0,0,0
turn	4:0,0,0,0;4:0,0,0,0
off	4:0,0,0,0
production	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
birth,	4:0,0,0,0
learn	4:0,0,0,0
again.	4:0,0,0,0
shortened	4:0,0,0,0
span	4:0,0,0,0
erythrocytes	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
needed	4:0,0,0,0
abolish	4:0,0,0,0
symptoms,	4:0,0,0,0
documented	4:0,0,0,0
variety	4:0,0,0,0
techniques	4:0,0,0,0
combination	4:0,0,0,0
increase	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
content	4:0,0,0,0;4:0,0,0,0
hbf	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
creased	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
amounts	4:0,0,0,0;4:0,0,0,0
biochemical	4:0,0,0,0
derivatives	4:0,0,0,0
catabolism.	4:0,0,0,0
30%,	4:0,0,0,0
possibly	4:0,0,0,0
20%.	4:0,0,0,0
absence	4:0,0,0,0
sequestration	4:0,0,0,0
children,	4:0,0,0,0;4:0,0,0,0
hbs-thalassemia	4:0,0,0,0
double	4:0,0,0,0
heterozygote.	4:0,0,0,0
subjects	4:0,0,0,0
ac	4:0,0,0,0
stroyed	4:0,0,0,0
unknown.	4:0,0,0,0
hemolytic	4:0,0,0,0;5:0,0,0,0
good	4:0,0,0,0
quired	4:0,0,0,0
turns	4:0,0,0,0
little.	4:0,0,0,0
evidence	4:0,0,0,0
deterioration	4:0,0,0,0
nonselective	4:0,0,0,0
loss	4:0,0,0,0;4:0,0,0,0
phospholipids	4:0,0,0,0
gain	4:0,0,0,0
calcium	4:0,0,0,0
probably,	4:0,0,0,0
according	4:0,0,0,0
jensen^^	4:0,0,0,0
alas,	4:0,0,0,0
prospects	4:0,0,0,0;4:0,0,0,0
still	4:0,0,0,0
dreams	4:0,0,0,0
reason.	4:0,0,0,0
claims	4:0,0,0,0
unsickling.	4:0,0,0,0
coup	4:0,0,0,0
beneficial	4:0,0,0,0
urea,	4:0,0,0,0
cyanate,	4:0,0,0,0
grace	4:0,0,0,0
doubt	4:0,0,0,0
either	4:0,0,0,0;4:0,0,0,0
mechanical	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
stresses	4:0,0,0,0
weakened	4:0,0,0,0
rigid	4:0,0,0,0
preventing	4:0,0,0,0
increasing	4:0,0,0,0
survival,	4:0,0,0,0
osmotic	4:0,0,0,0
lysis	4:0,0,0,0
impermeability	4:0,0,0,0
cations	4:0,0,0,0
undesirable	4:0,0,0,0
effects.	4:0,0,0,0
cyanate	4:0,0,0,0
tolerated	4:0,0,0,0
increases	4:0,0,0,0
eventually	4:0,0,0,0
lost.	4:0,0,0,0
well-estab	4:0,0,0,0
affinity	4:0,0,0,0;4:0,0,0,0
hba	4:0,0,0,0
indicates	4:0,0,0,0
discovery	4:0,0,0,0
lished	4:0,0,0,0
assoeiation	4:0,0,0,0
crises	4:0,0,0,0
hemolysis,	4:0,0,0,0
drugs	4:0,0,0,0
properties.	4:0,0,0,0
judging	4:0,0,0,0
within	4:0,0,0,0
occur	4:0,0,0,0;4:0,0,0,0
painless	4:0,0,0,0
“aplastic	4:0,0,0,0
crisis”	4:0,0,0,0
viral	4:0,0,0,0
congenital	4:0,0,0,0
es	4:0,0,0,0;4:0,0,0,0
fection	4:0,0,0,0
folic	4:0,0,0,0;5:0,0,0,0
depletion.^	4:0,0,0,0
sential	4:0,0,0,0
commodity	4:0,0,0,0
delivered	4:0,0,0,0
tissues.’	4:0,0,0,0
earliest	4:0,0,0,0
attempt	4:0,0,0,0
com	4:0,0,0,0
greatest	4:0,0,0,0
mortality	4:0,0,0,0
occurs	4:0,0,0,0
yr	4:0,0,0,0
age,	4:0,0,0,0
bat	4:0,0,0,0
pharmacologic	4:0,0,0,0
carl	4:0,0,0,0
principal	4:0,0,0,0
death	4:0,0,0,0
infection.	4:0,0,0,0
susceptibil	4:0,0,0,0
moore’s	4:0,0,0,0
group	4:0,0,0,0;4:0,0,0,0
1944.	4:0,0,0,0
inhibited	4:0,0,0,0
ity	4:0,0,0,0
infection,	4:0,0,0,0
pneumococci	4:0,0,0,0
osteomyelitis	4:0,0,0,0
survival	4:0,0,0,0;5:0,0,0,0
prolonged,*	4:0,0,0,0
artifically	4:0,0,0,0
salmonellae,	4:0,0,0,0
local	4:0,0,0,0
resistance	4:0,0,0,0
suppressed	4:0,0,0,0
erythropoiesis	4:0,0,0,0
stasis	4:0,0,0,0
marrow.*	4:0,0,0,0
propagating	4:0,0,0,0
resultant	4:0,0,0,0
net	4:0,0,0,0
lowering	4:0,0,0,0
circulating	4:0,0,0,0
level.”	4:0,0,0,0
infection	4:0,0,0,0;4:0,0,0,0
defect	4:0,0,0,0
“properdin”	4:0,0,0,0
system,	4:0,0,0,0
alternate	4:0,0,0,0
pathway	4:0,0,0,0
use	4:0,0,0,0
exchange	4:0,0,0,0
transfusion’	4:0,0,0,0
avoids	4:0,0,0,0
adds	4:0,0,0,0
c3	4:0,0,0,0
complement	4:0,0,0,0
activation,	4:0,0,0,0
defective	4:0,0,0,0
intracellular	4:0,0,0,0
killing	4:0,0,0,0
bac	4:0,0,0,0
sickle,	4:0,0,0,0
thus	4:0,0,0,0;4:0,0,0,0
reducing	4:0,0,0,0
teria	4:0,0,0,0
phagocytes	4:0,0,0,0
play	4:0,0,0,0
part.^“	4:0,0,0,0
addition,	4:0,0,0,0
splenectomy,	4:0,0,0,0
sufficiently	4:0,0,0,0
often	4:0,0,0,0
pecially	4:0,0,0,0
dysfunction	4:0,0,0,0
total	4:0,0,0,0
automatic	4:0,0,0,0
compensation	4:0,0,0,0
suppression	4:0,0,0,0
delivery	4:0,0,0,0
otherwise	4:0,0,0,0
minor	4:0,0,0,0
bacterial	4:0,0,0,0
invasion	4:0,0,0,0
desired.	4:0,0,0,0
success	4:0,0,0,0;4:0,0,0,0
treatment	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
established	4:0,0,0,0
rapidly	4:0,0,0,0
fatal	4:0,0,0,0
septicemia.	4:0,0,0,0
crisis	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
intravenous	4:0,0,0,0
hydration	4:0,0,0,0
alkalinlzation	4:0,0,0,0
variable	4:0,0,0,0
since	4:0,0,0,0
finally,	4:0,0,0,0
thinking	4:0,0,0,0
kass'”	4:0,0,0,0
1958.	4:0,0,0,0
systematic	4:0,0,0,0
ap	4:0,0,0,0
clinically	4:0,0,0,0
adverse	4:0,0,0,0
syndromes,	4:0,0,0,0
remember,	4:0,0,0,0
plication	4:0,0,0,0
remedies	4:0,0,0,0
oral	4:0,0,0,0
admirably	4:0,0,0,0
pointed	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
out	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
konotey-ahulu,^’	4:0,0,0,0
prophylaxis.	4:0,0,0,0
anemic,	4:0,0,0,0
“the	4:0,0,0,0
steady	4:0,0,0,0
state.”	4:0,0,0,0
case,	4:0,0,0,0
magnitude	4:0,0,0,0
health	4:0,0,0,0;5:0,0,0,0
problem	4:0,0,0,0
face	4:0,0,0,0
time.	4:0,0,0,0
milieu	4:0,0,0,0
gene	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
present	4:0,0,0,0
8%	4:0,0,0,0
million	4:0,0,0,0
22	4:0,0,0,0
interieur.	4:0,0,0,0
therefore,	4:0,0,0,0
meticulous	4:0,0,0,0
precipitating	4:0,0,0,0
citizens	4:0,0,0,0
united	4:0,0,0,0
states	4:0,0,0,0
causes	4:0,0,0,0
disability	4:0,0,0,0
determine	4:0,0,0,0
practical	4:0,0,0,0
point	4:0,0,0,0
entry	4:0,0,0,0
block	4:0,0,0,0
vicious	4:0,0,0,0
cy	4:0,0,0,0
varying	4:0,0,0,0
degrees	4:0,0,0,0
35,000	4:0,0,0,0
education	4:0,0,0,0
citi	4:0,0,0,0
cle	4:0,0,0,0
producing	4:0,0,0,0
crisis.	4:0,0,0,0
ago	4:0,0,0,0
castle‘s	4:0,0,0,0
zens	4:0,0,0,0
background	4:0,0,0,0
contrasting	4:0,0,0,0
con	4:0,0,0,0
theory	4:0,0,0,0
triggering	4:0,0,0,0
plasma	4:0,0,0,0
stitutional	4:0,0,0,0
manifestations	4:0,0,0,0;5:0,0,0,0
urgently	4:0,0,0,0
needed.	4:0,0,0,0
166	5:0,0,0,0
167	5:0,0,0,0
blacks	5:0,0,0,0
administrators	5:0,0,0,0
educational	5:0,0,0,0
institutions,	5:0,0,0,0
28.	5:0,0,0,0
rd,	5:0,0,0,0
minnich	5:0,0,0,0
v,	5:0,0,0,0
moore	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
cv:	5:0,0,0,0
ef	5:0,0,0,0
destruclion	5:0,0,0,0
xiii.	5:0,0,0,0
observa	5:0,0,0,0
industrial	5:0,0,0,0
organizations,	5:0,0,0,0
insurance	5:0,0,0,0
agencies.	5:0,0,0,0
role	5:0,0,0,0;5:0,0,0,0
pathogenesis	5:0,0,0,0;5:0,0,0,0
emphasized	5:0,0,0,0
strongly	5:0,0,0,0
neither	5:0,0,0,0
nor	5:0,0,0,0
arch	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
intern	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
med	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
101:355-363,	5:0,0,0,0
1958	5:0,0,0,0
disabled	5:0,0,0,0
cause.	5:0,0,0,0
dissemination	5:0,0,0,0
essential	5:0,0,0,0
trait.	5:0,0,0,0;5:0,0,0,0
j	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
lab	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
37:789	5:0,0,0,0
802,	5:0,0,0,0
1951	5:0,0,0,0
15.	5:0,0,0,0
ms,	5:0,0,0,0;5:0,0,0,0
kass	5:0,0,0,0;5:0,0,0,0
eh,	5:0,0,0,0;5:0,0,0,0
wb:	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
strict	5:0,0,0,0
objectivity.	5:0,0,0,0
29.	5:0,0,0,0
magdou'-fairchild	5:0,0,0,0
b,	5:0,0,0,0
swerdlow	5:0,0,0,0
ph,	5:0,0,0,0
studies	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
applied	5:0,0,0,0
tact,	5:0,0,0,0
jf:	5:0,0,0,0
intermolecular	5:0,0,0,0
oganization	5:0,0,0,0
x	5:0,0,0,0
ll,	5:0,0,0,0
influencing	5:0,0,0,0
determined	5:0,0,0,0
self-esteem	5:0,0,0,0
racial	5:0,0,0,0
pride	5:0,0,0,0;5:0,0,0,0
avoided.’^	5:0,0,0,0
screening	5:0,0,0,0
pro	5:0,0,0,0
pathologic	5:0,0,0,0
physiology	5:0,0,0,0
x-ray	5:0,0,0,0
diffraction.	5:0,0,0,0
239:217-219,	5:0,0,0,0
1972	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
grams	5:0,0,0,0
adequate	5:0,0,0,0
purpose	5:0,0,0,0
carry	5:0,0,0,0
psychological	5:0,0,0,0;5:0,0,0,0
related	5:0,0,0,0;5:0,0,0,0
disorders.	5:0,0,0,0;5:0,0,0,0
invest	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
30.	5:0,0,0,0
neel	5:0,0,0,0
jv:	5:0,0,0,0
inheritance	5:0,0,0,0
36:833	5:0,0,0,0
843,	5:0,0,0,0
hazards;	5:0,0,0,0
counseling	5:0,0,0,0
times	5:0,0,0,0
requires	5:0,0,0,0
science	5:0,0,0,0;5:0,0,0,0
110:64	5:0,0,0,0
66,	5:0,0,0,0
16.	5:0,0,0,0
ev,	5:0,0,0,0
eb:	5:0,0,0,0
careful	5:0,0,0,0
planning	5:0,0,0,0
application	5:0,0,0,0
“genocide”	5:0,0,0,0
31.	5:0,0,0,0
l,	5:0,0,0,0
itano	5:0,0,0,0
h,	5:0,0,0,0
sj,	5:0,0,0,0
al:	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
anemia:	5:0,0,0,0;5:0,0,0,0
report	5:0,0,0,0
greatly	5:0,0,0,0
avoided.	5:0,0,0,0
easy;	5:0,0,0,0
gelfand,'^	5:0,0,0,0
programs	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
sci	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
splenectomy;	5:0,0,0,0
ence	5:0,0,0,0
110:543-548,	5:0,0,0,0
persuasion	5:0,0,0,0
“must	5:0,0,0,0
directed	5:0,0,0,0
individuals	5:0,0,0,0
succeed	5:0,0,0,0
extent	5:0,0,0,0
39:223	5:0,0,0,0
254,	5:0,0,0,0
32.	5:0,0,0,0
pearson	5:0,0,0,0
ha,	5:0,0,0,0
spencer	5:0,0,0,0
rp,	5:0,0,0,0
cornelius	5:0,0,0,0
ea:	5:0,0,0,0
17.	5:0,0,0,0
th,	5:0,0,0,0;5:0,0,0,0
self-interest	5:0,0,0,0
evident	5:0,0,0,0
far	5:0,0,0,0
distant.”	5:0,0,0,0
herein	5:0,0,0,0
lies	5:0,0,0,0
functional	5:0,0,0,0
asplenia	5:0,0,0,0
hypotonic	5:0,0,0,0
erythrostasis	5:0,0,0,0
obstacle	5:0,0,0,0
promoting	5:0,0,0,0
out-breeding	5:0,0,0,0
transmissible	5:0,0,0,0
engl	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
281:923-926,	5:0,0,0,0
1969	5:0,0,0,0;5:0,0,0,0
hemolysis	5:0,0,0,0
certain	5:0,0,0,0;5:0,0,0,0
anemias,	5:0,0,0,0
defect.	5:0,0,0,0
33.	5:0,0,0,0
reinhard	5:0,0,0,0
cv,	5:0,0,0,0;5:0,0,0,0
dubach	5:0,0,0,0
r,	5:0,0,0,0
assoc	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
am	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;6:0,0,0,0
55:127-132,	5:0,0,0,0
david	5:0,0,0,0
nathan	5:0,0,0,0
depressant	5:0,0,0,0
18.	5:0,0,0,0
jw:	5:0,0,0,0
inspired	5:0,0,0,0
erythrocytogenesis:	5:0,0,0,0
ob	5:0,0,0,0
termed	5:0,0,0,0
“focussed	5:0,0,0,0
counseling”	5:0,0,0,0
based	5:0,0,0,0
particular	5:0,0,0,0
pregnancy	5:0,0,0,0;5:0,0,0,0
risk,	5:0,0,0,0
v	5:0,0,0,0
lll.	5:0,0,0,0
servations	5:0,0,0,0
solutions.	5:0,0,0,0
proc	5:0,0,0,0
soc	5:0,0,0,0
exp	5:0,0,0,0
suitable	5:0,0,0,0
mixed	5:0,0,0,0
placental	5:0,0,0,0
obtained	5:0,0,0,0
toxic	5:0,0,0,0
manifesta	5:0,0,0,0
biol	5:0,0,0,0
75:197-201,	5:0,0,0,0
1950	5:0,0,0,0
safely	5:0,0,0,0
reliably.^^	5:0,0,0,0
technique,	5:0,0,0,0
23:682	5:0,0,0,0
698,	5:0,0,0,0
1944	5:0,0,0,0;5:0,0,0,0
19.	5:0,0,0,0
jw,	5:0,0,0,0
brewster	5:0,0,0,0
hh,	5:0,0,0,0
synthesized	5:0,0,0,0
trimester	5:0,0,0,0
34.	5:0,0,0,0
rosen	5:0,0,0,0
fs:	5:0,0,0,0
sickle-cell	5:0,0,0,0
x.	5:0,0,0,0
detected	5:0,0,0,0
6-8-cm	5:0,0,0,0
fetuses,	5:0,0,0,0
parents	5:0,0,0,0
properdin	5:0,0,0,0
system.	5:0,0,0,0
287:489	5:0,0,0,0
494,	5:0,0,0,0
biophysics	5:0,0,0,0
avoid	5:0,0,0,0
bringing	5:0,0,0,0
into	5:0,0,0,0
world	5:0,0,0,0
destined	5:0,0,0,0
97:145	5:0,0,0,0
-168,	5:0,0,0,0
35.	5:0,0,0,0
rucknagel	5:0,0,0,0
dl:	5:0,0,0,0;5:0,0,0,0
genetics	5:0,0,0,0
20.	5:0,0,0,0
herrick	5:0,0,0,0
jb:	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
peculiar	5:0,0,0,0
cell-thalassemia	5:0,0,0,0
americans	5:0,0,0,0
syndromes.	5:0,0,0,0
justifiable	5:0,0,0,0
vigorous	5:0,0,0,0
concerned	5:0,0,0,0
133:595	5:0,0,0,0
606,	5:0,0,0,0
1974	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
25:	5:0,0,0,0
search,	5:0,0,0,0
education,	5:0,0,0,0
service	5:0,0,0,0
way.	5:0,0,0,0
36.	5:0,0,0,0
jb,	5:0,0,0,0
waugh	5:0,0,0,0
tr:	5:0,0,0,0
553-561,1910	5:0,0,0,0
stimulate	5:0,0,0,0
support	5:0,0,0,0
initia	5:0,0,0,0
23:375-	5:0,0,0,0
21.	5:0,0,0,0
ingram	5:0,0,0,0
vm:	5:0,0,0,0
mutations	5:0,0,0,0
imagination	5:0,0,0,0
areas	5:0,0,0,0
made,	5:0,0,0,0
ways	5:0,0,0,0
380,1930	5:0,0,0,0
hemoglobin:	5:0,0,0,0;5:0,0,0,0
chemical	5:0,0,0,0
37.	5:0,0,0,0
sc,	5:0,0,0,0;5:0,0,0,0
wb,	5:0,0,0,0
fleming	5:0,0,0,0;5:0,0,0,0
em:	5:0,0,0,0
presently	5:0,0,0,0
apparent.	5:0,0,0,0
haemoglobin.	5:0,0,0,0;5:0,0,0,0
perimental	5:0,0,0,0
180:326-328,	5:0,0,0,0
erythrocytes.	5:0,0,0,0
22.	5:0,0,0,0
jh,	5:0,0,0,0
simmons	5:0,0,0,0
rl,	5:0,0,0,0
references	5:0,0,0,0
100:387-389,	5:0,0,0,0
filtration	5:0,0,0,0
1.	5:0,0,0,0;5:0,0,0,0
allison	5:0,0,0,0
ac:	5:0,0,0,0
properlies	5:0,0,0,0
38.	5:0,0,0,0
em,	5:0,0,0,0
7.	5:0,0,0,0
charache	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
s:	5:0,0,0,0
anemias.	5:0,0,0,0
18:133	5:0,0,0,0
148,	5:0,0,0,0
biochem	5:0,0,0,0
65:212-219,	5:0,0,0,0
133:698-705,	5:0,0,0,0
23.	5:0,0,0,0
wn:	5:0,0,0,0
fragmentation	5:0,0,0,0
2.	5:0,0,0,0
alperin	5:0,0,0,0
deficiency	5:0,0,0,0
com-	5:0,0,0,0
erythrocytes:	5:0,0,0,0;5:0,0,0,0
8.	5:0,0,0,0
s,	5:0,0,0,0;5:0,0,0,0
page	5:0,0,0,0
“freakish	5:0,0,0,0
poikilocyte."	5:0,0,0,0
257:	5:0,0,0,0
plicaling	5:0,0,0,0
ann	5:0,0,0,0
4:498	5:0,0,0,0
355-364,1969	5:0,0,0,0
120:298-306,	5:0,0,0,0
1967	5:0,0,0,0;5:0,0,0,0
67:1195-1200,	5:0,0,0,0
504,	5:0,0,0,0
24.	5:0,0,0,0
wn,	5:0,0,0,0
bromberg	5:0,0,0,0
pa,	5:0,0,0,0
barefield	5:0,0,0,0
k:	5:0,0,0,0
3.	5:0,0,0,0
armaly	5:0,0,0,0
mf:	5:0,0,0,0
ocular	5:0,0,0,0
manifeslalions	5:0,0,0,0
39.	5:0,0,0,0
sherman	5:0,0,0,0
lj:	5:0,0,0,0
phenomenon,	5:0,0,0,0
9.	5:0,0,0,0
weatherall	5:0,0,0,0
dj,	5:0,0,0,0
clegg	5:0,0,0,0
deformation:	5:0,0,0,0
inlern	5:0,0,0,0
133:670-	5:0,0,0,0
reference	5:0,0,0,0
differentiation	5:0,0,0,0
polycythemia	5:0,0,0,0
hemoglobinop	5:0,0,0,0
abstracted,	5:0,0,0,0
res	5:0,0,0,0
17:	5:0,0,0,0
679,1974	5:0,0,0,0
athy.	5:0,0,0,0
45:813-822,	5:0,0,0,0
1966	5:0,0,0,0
464,	5:0,0,0,0
4.	5:0,0,0,0
bauer	5:0,0,0,0
j:	5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
disease:	5:0,0,0,0;5:0,0,0,0
pathogenic,	5:0,0,0,0
bull	5:0,0,0,0
hopkins	5:0,0,0,0
hosp	5:0,0,0,0
67:309-324,	5:0,0,0,0
10.	5:0,0,0,0
lw:	5:0,0,0,0
25.	5:0,0,0,0
kan	5:0,0,0,0
yw,	5:0,0,0,0
dozy	5:0,0,0,0
am,	5:0,0,0,0
alter	5:0,0,0,0
bp,	5:0,0,0,0
considerations.	5:0,0,0,0
moist	5:0,0,0,0
40.	5:0,0,0,0
k,	5:0,0,0,0
l:	5:0,0,0,0
tection	5:0,0,0,0
fetus:	5:0,0,0,0
surg	5:0,0,0,0
41:1344-1362,	5:0,0,0,0
17:913-920,	5:0,0,0,0
viii.	5:0,0,0,0
intrauterine	5:0,0,0,0
diagnosis	5:0,0,0,0
5.	5:0,0,0,0
jf,	5:0,0,0,0;5:0,0,0,0
milner	5:0,0,0,0
pfa:	5:0,0,0,0
biologic	5:0,0,0,0
di	5:0,0,0,0
11.	5:0,0,0,0
lw,	5:0,0,0,0
erythrocyte	5:0,0,0,0
287:1-5,	5:0,0,0,0
agnostic	5:0,0,0,0
significance.	5:0,0,0,0
8:1008	5:0,0,0,0
1023,	5:0,0,0,0
jama	5:0,0,0,0
112:695-701,	5:0,0,0,0
26.	5:0,0,0,0
pp,	5:0,0,0,0
lessin	5:0,0,0,0
ls,	5:0,0,0,0
radice	5:0,0,0,0
p:	5:0,0,0,0
rheologi	5:0,0,0,0
heterogeneous	5:0,0,0,0
distribution	5:0,0,0,0
41.	5:0,0,0,0
watson	5:0,0,0,0
significance	5:0,0,0,0
paucity	5:0,0,0,0
12.	5:0,0,0,0
emmel	5:0,0,0,0
ve:	5:0,0,0,0
cal	5:0,0,0,0
aspects	5:0,0,0,0
47:1731-	5:0,0,0,0
newborn	5:0,0,0,0
negro	5:0,0,0,0
infants.	5:0,0,0,0
133:577-590,	5:0,0,0,0
1741,	5:0,0,0,0
1968	5:0,0,0,0;5:0,0,0,0
215:419-423,	5:0,0,0,0
27.	5:0,0,0,0
fid:	5:0,0,0,0
6.	5:0,0,0,0
callender	5:0,0,0,0
ste,	5:0,0,0,0
nickel	5:0,0,0,0
20:586-599,	5:0,0,0,0
42.	5:0,0,0,0
whitten	5:0,0,0,0
cf:	5:0,0,0,0
dietary	5:0,0,0,0
protein	5:0,0,0,0
diseases:	5:0,0,0,0
including	5:0,0,0,0
measuring	5:0,0,0,0
concentrating	5:0,0,0,0
13.	5:0,0,0,0
gelfand	5:0,0,0,0
hm:	5:0,0,0,0
concepts	5:0,0,0,0
eradi	5:0,0,0,0
“sickle	5:0,0,0,0
crises.”	5:0,0,0,0
133:611-619,	5:0,0,0,0
transfused	5:0,0,0,0
cation	5:0,0,0,0
control.	5:0,0,0,0
pharos	5:0,0,0,0
37:13,	5:0,0,0,0
jan.	5:0,0,0,0
115:262-266,	5:0,0,0,0
34:90-104,	5:0,0,0,0
14.	5:0,0,0,0
efi:	5:0,0,0,0
&	6:0,0,0,0
stratton	6:0,0,0,0
journals	6:0,0,0,0
blo	6:0,0,0,0
—	6:0,0,0,0;6:0,0,0,0
journal	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
er	6:0,0,0,0
ic	6:0,0,0,0;6:0,0,0,0
society	6:0,0,0,0;6:0,0,0,0
em	6:0,0,0,0;6:0,0,0,0
ato	6:0,0,0,0;6:0,0,0,0
ernst	6:0,0,0,0;6:0,0,0,0
r.	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
jatte.	6:0,0,0,0
editor	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
onthly	6:0,0,0,0
u.s.:	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
$45.00	6:0,0,0,0
per	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
year	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
foreign:	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
s4h.50	6:0,0,0,0
comprehensive	6:0,0,0,0
psychiatry	6:0,0,0,0
ohicial	6:0,0,0,0
psychopathological	6:0,0,0,0
fritz	6:0,0,0,0
a.	6:0,0,0,0;6:0,0,0,0
freyhan,	6:0,0,0,0
bimonthly	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
u.	6:0,0,0,0
.:	6:0,0,0,0
$28.00	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
$31.00	6:0,0,0,0;6:0,0,0,0
pediatric	6:0,0,0,0;6:0,0,0,0
surgery	6:0,0,0,0;6:0,0,0,0
official	6:0,0,0,0;6:0,0,0,0
surgical	6:0,0,0,0;6:0,0,0,0
section	6:0,0,0,0
academy	6:0,0,0,0
pediatrics,	6:0,0,0,0
british	6:0,0,0,0
paediatric	6:0,0,0,0
surgeons,	6:0,0,0,0
c.	6:0,0,0,0
everett	6:0,0,0,0
koop,	6:0,0,0,0
ed	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
uc	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
atio	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
robert	6:0,0,0,0;6:0,0,0,0
l.	6:0,0,0,0
kalapos,	6:0,0,0,0
$10.50	6:0,0,0,0
$18.50	6:0,0,0,0
quarterly	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
etabo	6:0,0,0,0
lism	6:0,0,0,0
linical	6:0,0,0,0
field,	6:0,0,0,0
$41.00	6:0,0,0,0
li.s.:	6:0,0,0,0
$38.00	6:0,0,0,0
monthly	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
cardio	6:0,0,0,0
diseases	6:0,0,0,0
edmund	6:0,0,0,0
h.	6:0,0,0,0;6:0,0,0,0
sonnenblick,	6:0,0,0,0
editor,	6:0,0,0,0
michael	6:0,0,0,0
lesch,	6:0,0,0,0
co-editor	6:0,0,0,0
$30.50	6:0,0,0,0
$27.50	6:0,0,0,0;6:0,0,0,0
6	6:0,0,0,0
issues	6:0,0,0,0;6:0,0,0,0
seminars	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
arthritis	6:0,0,0,0
rheumatism	6:0,0,0,0
john	6:0,0,0,0;6:0,0,0,0
talbott,	6:0,0,0,0
lj.s.:	6:0,0,0,0
$24.50	6:0,0,0,0;6:0,0,0,0
4	6:0,0,0,0
sem	6:0,0,0,0;6:0,0,0,0
inars	6:0,0,0,0;6:0,0,0,0
peter	6:0,0,0,0
miescher	6:0,0,0,0
jaffe,	6:0,0,0,0
editors	6:0,0,0,0;6:0,0,0,0
$27.00	6:0,0,0,0;6:0,0,0,0
$24.00	6:0,0,0,0
nuclear	6:0,0,0,0
edicine	6:0,0,0,0
leonard	6:0,0,0,0
m.	6:0,0,0,0;6:0,0,0,0
freeman	6:0,0,0,0
donald	6:0,0,0,0
blaufox,	6:0,0,0,0
$25.00	6:0,0,0,0;6:0,0,0,0
yarbro.	6:0,0,0,0
$22.50	6:0,0,0,0
roen	6:0,0,0,0
tg	6:0,0,0,0
en	6:0,0,0,0
benjamin	6:0,0,0,0
felson,	6:0,0,0,0
transplantatio	6:0,0,0,0
proceedings	6:0,0,0,0
transplantation	6:0,0,0,0
felix	6:0,0,0,0
t.	6:0,0,0,0
rapaport,	6:0,0,0,0
$33.75	6:0,0,0,0
$31.75	6:0,0,0,0
io	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
jo	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
nal	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
review—	6:0,0,0,0
n.	6:0,0,0,0
mcclelland,	6:0,0,0,0
$90.00	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
$70.00	6:0,0,0,0;6:0,0,0,0;6:0,0,0,0
th	6:0,0,0,0
alm	6:0,0,0,0
douglas	6:0,0,0,0
anderson,	6:0,0,0,0
:	6:0,0,0,0
iv	6:0,0,0,0
disorders:	6:0,0,0,0
larry	6:0,0,0,0
bradford,	6:0,0,0,0
monthlies	6:0,0,0,0
.s.:	6:0,0,0,0